FDA
approval
· 2022-06-27
FDA Approved: TRANYLCYPROMINE — Original Application (Solco Healthcare US, LLC)
Summary
FDA approves an original application for generic tranylcypromine, a monoamine oxidase inhibitor used for major depressive disorder, manufactured by Solco Health…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TRANYLCYPROMINE (TRANYLCYPROMINE)